Human Medicines Registration
The Human Medicines and Diagnostics Registration Division is responsible for:
Conducting scientific evaluation of submitted products’ dossiers to assess quality, safety, and efficacy of the below products prior to the granting of Marketing Authorization (MA):
i. Pharmaceutical and other health products
human medicines and vaccines ;
narcotics and psychotropic drugs, and other controlled substances;
blood and blood products;
biopharmaceutical products;
radiopharmaceutical products;
nanotechnology-based drugs and therapies;
advanced therapies including gene-therapies,
cell-based products and regenerative medicines;
other human and biological products used as medicines;
Clinical trial investigational products regulated under the scope of this Order;
Herbal medicines;
Tobacco and nicotine products;